Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, Synthesis, Docking Study, and Antiproliferative Evaluation of Novel Schiff Base–Benzimidazole Hybrids with VEGFR-2 Inhibitory Activity
Hany M. Abd El‐Lateef, Mohammed A. I. Elbastawesy, Tamer Mohamed Abdelghani Ibrahim, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 481-481
Open Access | Times Cited: 11

Showing 11 citing articles:

Recent advances in nitrogen-containing heterocyclic compounds as receptor tyrosine kinase inhibitors for the treatment of cancer: Biological activity and structural activity relationship
Keshav Taruneshwar Jha, Abhimannu Shome, Chahat, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106680-106680
Closed Access | Times Cited: 26
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies
Bahaa G. M. Youssif, Martha M. Morcoss, Stefan Bräse, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 446-446
Open Access | Times Cited: 6
Design, synthesis, antimalarial activity, and in-silico studies of new benzimidazole/pyridine hybrids as dihydrofolate reductase inhibitors
Martha M. Morcoss, Jakline Nelson Saddik, Mariam E. Amin, et al.
Bioorganic Chemistry (2025), pp. 108171-108171
Closed Access
Benzimidazole‐Containing Compounds as Anticancer Agents
Ulviye Acar Çevik, Ayşen Işık, Betül Kaya, et al.
ChemistrySelect (2024) Vol. 9, Iss. 32
Closed Access | Times Cited: 1
Synthesis, Biological Investigation, and Molecular Docking of Novel Benzimidazole‐Hydrazone Hybrids as Potential Anticancer Agent Candidates
Serpil Demirci, Tuğba Kul Köprülü, Arif Mermer, et al.
ChemistrySelect (2024) Vol. 9, Iss. 9
Closed Access | Times Cited: 1
New benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study
Ulviye Acar Çevik, İsmail Çeli̇k, Şennur Görgülü, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Open Access | Times Cited: 1
Discovery of Novel Mono-Carbonyl Curcumin Derivatives as Potential Anti-Hepatoma Agents
Weiya Cao, Pan Yu, Shilong Yang, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6796-6796
Open Access | Times Cited: 2
A critical analysis of design, binding pattern and SAR of benzo-fused heteronuclear compounds as VEGFR-2 inhibitors
Mayank Kashyap, Saurabh Gupta, Yogita Bansal, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 115, pp. 117966-117966
Closed Access
Design, synthesis, biological evaluation, and in silico studies of novel N-substituted-2-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazole-6-carboxamides as promising anticancer agents
Navid Dastyafteh, Manica Negahdaripour, Mohammad Hosein Sayahi, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35323-35335
Open Access
Discovery of novel VEGFR2 inhibitors against non-small cell lung cancer based on fingerprint-enhanced graph attention convolutional network
Zixiao Wang, Lili Sun, Yu Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Therapeutic Potential of Schiff and Mannich Bases of 2-Substituted Benzimidazole Analogues
Ritchu Babbar, Swikriti Makkar, Sandeep Arora, et al.
International Journal of Drug Delivery Technology (2022) Vol. 13, Iss. 02, pp. 753-758
Open Access
Page 1

Scroll to top